Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 23 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

26%

6 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
5(38.5%)
Phase 3
4(30.8%)
Phase 4
2(15.4%)
Phase 1
2(15.4%)
13Total
N/A(5)
Phase 3(4)
Phase 4(2)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT05871099Phase 3Recruiting

Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not

Role: collaborator

NCT07402135Not ApplicableNot Yet Recruiting

Fecal Noninvasive Biomarkers Oriented Control Versus Usual Care Strategy in Ulcerative Colitis

Role: collaborator

NCT06462313Not ApplicableCompleted

Dobutamine for Management of Surgical Patients With Septic Shock

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT07111273Not Yet Recruiting

DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis

Role: collaborator

NCT07111572Not Yet Recruiting

Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis

Role: collaborator

NCT05352802Not ApplicableActive Not Recruiting

Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric Cancer

Role: collaborator

NCT06285734Recruiting

Clinical Characteristics of Small Intestinal Bacterial Overgrowth in Individuals with Abdominal Distention

Role: collaborator

NCT06649422Not Yet Recruiting

Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study

Role: collaborator

NCT05794425Phase 1Recruiting

Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders

Role: collaborator

NCT04305106Phase 3Unknown

Bevacizumab in Patients With Severe Covid-19

Role: collaborator

NCT05901779Not ApplicableUnknown

Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy

Role: collaborator

NCT05159947Phase 3Unknown

SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial

Role: collaborator

NCT03786666Completed

Ultrasound Evaluation of Carotid Artery Atherosclerotic Plaques and Recanalization

Role: collaborator

NCT04856423Unknown

Ultra-sensitivity Quantitative Fecal Immunochemical Test in Detecting Colorectal Advanced Adenoma and Colorectal Cancer

Role: collaborator

NCT04901117Phase 4Unknown

Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days

Role: collaborator

NCT04636099Not ApplicableUnknown

Gastrointestinal Surgery Study Group 2001

Role: collaborator

NCT03719820Unknown

Stroke Imaging Package Study of Intracranial Atherosclerosis ( SIPS-ICAS )

Role: collaborator

NCT03930940Phase 1Completed

Remote Ischemic Conditioning for Intracerebral Hemorrhage

Role: collaborator

NCT04069975Unknown

Sedation Versus No Sedation for Detection Rates of Precancerous Lesions and Cancer

Role: collaborator